Catalyst Wire Dossier Catalyst Wire Dossier

AVA6000

· Avacta Life Sciences Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AVA6000, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours [Phase 1]

See pricing